Director/Senior Director of Analytical Development
5AM Ventures
Director/Senior Director of Analytical Development
5AM Ventures
Venture capital investing in life-science innovations
Salary Range: 225000 to 275000 (Currency: USD) (Pay period: per-year-salary)
Analytical Development Strategy
Method Development, Qualification & Validation
Peptide / PEG Analytical Development
GMP & Clinical Readiness
External Partner Management
Leadership & Cross-Functional Collaboration
Preferred
We believe in building an inclusive and balanced team, and we know that strong candidates may not meet every qualification listed. If this opportunity interests you, we encourage you to apply.
Prolynx is an equal opportunity employer. We do not discriminate based on race, color, religion, national origin, age, sex, sexual orientation, gender identity, marital status, ancestry, physical or mental disability, veteran status, or any other status protected by applicable law.
Prolynx does not accept unsolicited resumes from recruitment agencies or external recruiters. No fees will be paid for unsolicited submissions.
Venture capital investing in life-science innovations
5AM Ventures is an investment firm focused on backing advanced life science innovations. It diversifies its bets across biopharmaceutical therapeutics and platform technologies, investing within multiple therapeutic areas and modalities. Its approach targets opportunities built on innovative platform platforms, corporate spin-offs, and products with shorter development timelines. The firm’s “product” is providing capital, strategic guidance, and resources to portfolio companies to help them reach clinically or commercially viable milestones faster. Unlike some investors that emphasize a single niche, 5AM differentiates itself by breadth across life science sectors and a focus on technologies with the potential for quicker development cycles. The firm’s goal is to create value by supporting responsible, science-driven progress in life sciences and helping portfolio companies advance promising therapies and platforms to patients and markets.
Explore more opportunities at 5AM Ventures